(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. Only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure.
Contents:
Preface.- 1. Therapeutic control of hepatitis C virus - the role of neutralizing monoclonal antibodies.- 2. Antibodies for HIV treatment and prevention: window of opportunity?.- 3. Human monoclonal antibody and vaccine approaches to prevent human rabies.- 4. Immunoprophylaxis of RSV infection: from RSV-IGIV to palivizumab and motavizumab.- 5. The molecular basis of antibody protection against West Nile Virus.- 6. Exploring the native human antibody repertoire to create anti-viral therapeutics.- Subject index.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: November, 2010
Pages: 204
Weight: 320g
Availability: Available
Subcategories: Microbiology
Publisher recommends
From the same series
